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Objective To study the possibility of reporting results of identiﬁcation and susceptibility
testing of Gram-negative bacilli the same day as bacteremia is detected by using direct
inoculation from positive blood cultures (Bactec 9240) into VITEK GNIþ and GNS-GA
cards.
Methods All blood cultures with Gram-negative enteric bacillus-like morphology on
microscopy found to be positive onworkdays between 15 June 1999 and 29 February 2000
were included. Identiﬁcation and susceptibility testing were done by three methods: the
direct method using a suspension made by differential centrifugation of positive blood
culture broth for inoculation of the VITEK cards; the standardmethod using an inoculum
made from an overnight culture on a solid media; and the routine method (reference
method) using conventional testing.
Results Of 169 isolates, the direct method resulted in 75% correct identiﬁcations, 9%
misidentiﬁcations and 17% non-identiﬁcations. All misidentiﬁed isolates were Escherichia
coli, of which 80% were reported as Salmonella arizonae. Five biochemical tests yielded
most of the aberrant results; correcting the citrate and malonate reactions in most cases
led to correct identiﬁcation by the VITEK database. Despite a negative H2S reaction, 11 E.
coli isolates were reported as S. arizonae. Two-thirds (69%) of identiﬁcations were
reported within 6 h, and 95% of these were correct. The direct susceptibility testing
method was assessable for 140 isolates. Correct results were found in 99% of isolate–
antimicrobial combinations, and 85% were reported within 6 h.
Conclusion The direct VITEKmethod could correctly report identiﬁcations and suscept-
ibility patterns within 6 h, making same-day reporting possible for almost two-thirds
(63%) of bacteremic episodes with Gram-negative bacilli. These results could probably be
improved by modiﬁcation of the identiﬁcation algorithms of the VITEK software.
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INTRODUCTION
Detection of bloodstream infections is one of the
most relevant tasks performed by the clinical
microbiology laboratory. Rapid bacterial identiﬁ-
cation and susceptibility testing in bacteremic
patients improves patient therapy and outcome,
and reduces patient cost [1–3].
Both automated blood culture systems and
automated systems for identiﬁcation and suscept-
ibility testing of bacteria have been on the market
for a number of years. Several studies have ex-
plored the possibility of combining these systems
to achieve rapid identiﬁcation and susceptibility
testing by direct inoculation from positive blood
cultures [4–8]. However, the clinical performance
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is dependent on which systems are used and
a thorough evaluation of each combination is
recommended [9]. The VITEK Gram-negative
identiﬁcation plus (GNIþ) card (bioMe´rieux, La-
Balme-Les-Grottes, France) has only recently been
introduced to the market (in 1997). Evaluation and
comparison studies have been performed [10–12],
but the accuracy of identiﬁcation with the VITEK
GNIþ card when inoculated directly from positive
blood cultures has not been studied so far.
In order to study the possibility of reporting
results of identiﬁcation and susceptibility testing
of Gram-negative bacilli on the same day as the
bacteremia is detected, we evaluated the accuracy
and speed of direct identiﬁcation (GNIþ card) and
susceptibility testing (GNS-GA card) using the
VITEK.
MATERIAL AND METHODS
Blood cultures were screened for growth of micro-
organisms using the Bactec 9240 system (Becton
Dickinson, Cockeysville, MD, USA). The study
period was daytime on workdays between 15 June
1999 and 29 February 2000. One blood culture set
consisted of two Bactec PLUS aerobic/F  bottles
and one Bactec PLUS anaerobic/F  bottle. One
bottle per positive set was investigated by the
direct VITEK method (aerobic bottle preferable).
Only blood culture sets with Gram-negative
enteric bacillus-like morphology on microscopy
were included. The VITEK instrument was used
with software release R06.01.
Identification
Identiﬁcation was performed using three different
methods. By the direct method a 5-mL sample
from the positive blood culture bottle was centri-
fuged at 160 g for 5min to pellet blood cells and
particulate culture material. The supernatant was
then centrifuged at 650 g for 10min to pellet bac-
teria. This pellet was used for an oxidase test and
to make a McFarland no. 1 standard suspension in
1.8mL of 0.45% saline using the VITEK Colori-
meter. The suspension was then inoculated into
the VITEK GNIþ card and processed according to
the manufacturer’s recommendations. The proce-
dure for the standard method of identiﬁcation was
as above, except that a suspension (McFarland no.
1 standard) was made from an overnight agar
culture. The routine method for identiﬁcation of
Gram-negative bacteria was based on extensive
conventional characterization and was considered
to be the standard [13,14].
Six Salmonella arizonae/diarizonae strains were
used in simulated blood cultures to study the
H2S reaction of these strains in the GNIþ card
by the direct method.
Susceptibility testing
Susceptibility testing was also performed using
three different methods. For both the direct
method and the standard method, 50-mL samples
of the respective McFarland no. 1 standard sus-
pension used for the GNIþ card were diluted in
1.8mL 0.45% saline and inoculated into the VITEK
GNS-GA card. The routine method for suscept-
ibility testing employed Neo-Sensitabs (User’s
Guide to Neo-Sensitabs, 11 edn, Rosco, Taastrup,
Denmark) on Danish Blood agar (SSI Diagnostika,
Hillerød, Denmark) using a semi-conﬂuent inocu-
lum and reading after overnight incubation at
37 8C in ambient air. The following antibiotics
were tested: ampicillin, cefuroxime, ceftriaxone,
ceftazidime, gentamicin, tobramycin and cipro-
ﬂoxacin. In case of disagreement between the
routine tablet diffusion method and the VITEK
methods (including when this was due to differ-
ences in interpretative breakpoints), the suscept-
ibility of the isolate was retested using the Etest on
Mueller Hinton agar (Becton Dickinson) according
to the manufacturer’s guidelines (AB Biodisk,
Etest manual, edn. 2000). The result of the Etest,
which uses the same interpretative breakpoints as
the VITEK, was taken as the standard.
Definitions and analysis
In each bacteremic episode, only one positive blood
culture set of any given species was included (no
repeat cultures). Two positive blood culture sets
(same species and susceptibility pattern) from
the same patient were by deﬁnition considered
to belong to the same bacteremic episode if the
interval between blood culture samplings was
14days or less. Isolates with unacceptable identi-
ﬁcation results (probability numbers of <90%)
were regarded as not identiﬁed [10], and these
isolates described as having a ‘Questionable
biopattern’, or ‘Good conﬁdence, marginal separa-
tion’ were grouped together with the unidentiﬁed
isolates (‘No identiﬁcation’).
Hansen et al Direct identification and susceptibility from blood 39
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 8, 38–44
Only isolates identiﬁed with a probability num-
ber 90% were evaluated in the susceptibility
testing part of the present study, since the VITEK
algorithm for susceptibility testing is dependent
on species-speciﬁc growth curves. Susceptibility
discrepancies were reported as very major errors
(false susceptibility), major errors (false resistance)
or minor errors (susceptible/resistant vs. inter-
mediate susceptibility).
RESULTS
Of 186 blood culture sets included by microscopy,
17 were excluded due to growth of Gram-negative
anaerobes (n¼ 8), Gram-negative fastidious bacilli
(n¼ 4), Gram-positive bacilli (n¼ 1), or polymicro-
bial growth (n¼ 4). The 12 anaerobic or fastidious
bacilli did not grow well enough to generate iden-
tiﬁcation and susceptibility data. One Bacillus sp.
(Gram-negative on initial Gram stain) and one
Enterobacter cloacae–Enterococcus faecalis mixture
among four polymicrobial cultures were reported
as unidentiﬁed. The other three polymicrobial
cultures were reported with identiﬁcation of the
bacteriummost active biochemically, and with the
susceptibility pattern of the most resistant bacter-
ium. Thus, a total of 169 blood culture sets from
165 patients were able to be evaluated for assess-
ment of the accuracy and speed of direct identiﬁ-
cation and susceptibility testing.
Identification
The oxidase test is a prerequisite for the VITEK
identiﬁcation algorithm. Identical results were
obtained with pelleted bacteria (blood cultures)
and with colony material (agar plates).
In Table 1, the direct VITEK method is com-
pared with the routine method. A total of 126
(75%) isolates were correctly identiﬁed, 28 (17%)
were unidentiﬁed, and 15 (9%) were misidentiﬁed
(all Escherichia coli). The unidentiﬁed group con-
sisted of 22 isolates reported as unidentiﬁed and
six isolates identiﬁed to species or genus level with
probability numbers <90%.
Table 2 shows the results of the ﬁve biochemical
tests that yielded for most of the aberrant results:
urease, H2S and utilization of citrate and malonate
(false-positive results) and lysine decarboxylase
(false-negative results) for the six isolates with
probability numbers <90% and the 15 misidenti-
ﬁed isolates. A total of 20 of the 21 isolates were E.
coli. The 21 isolates were mainly misidentiﬁed or
achieved probability numbers <90% due to false-
positive reactions in the malonate (n¼ 17) and the
citrate (n¼ 16) tests. By manually changing posi-
tive results to negative for citrate and malonate in
the VITEK bionumber, 12 of these 21 isolates were
correctly identiﬁed by the VITEK database.
Only one of 12 E. coli isolates reported as S.
arizonae was H2S positive, while all of the six S.
arizonae/diarizonae strains from simulated blood
cultures tested by the direct method were H2S
positive. In contrast, the 21 isolates listed in Table 2
showed no false-positive reactions for the urease,
H2S and citrate tests and only three false-positive
malonate tests when tested by the standard VITEK
method.
The percentages of correctly identiﬁed, un-
identiﬁed, or misidentiﬁed isolates in relation to
Table 1 Identification of 169 isolates from positive blood culture by direct inoculation of the GNIþ card using VITEK as
compared to routine (conventional) identification
Species
Correct
identification
No
identification Misidentification
Total
number
Escherichia coli 71 17 15 103
Klebsiella pneumoniae 18 1 0 19
Salmonella spp. 6 5 0 11
Proteus mirabilis 6 2 0 8
Pseudomonas aeruginosa 9 2 0 11
Enterobacter cloacae 4 0 0 4
Klebsiella oxytoca 8 0 0 8
Citrobacter koseri 2 0 0 2
Proteus vulgaris 1 1 0 2
Serratia marcescens 1 0 0 1
Total number 126 28 15 169
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detection time are shown in Table 3. Sixty-nine
percent (117/169) of the VITEK identiﬁcations
were made within 6 h, and 95% (111/117) of these
were correct, whereas only 29% (15/52) of isolates
identiﬁed after 7 or 8 h of incubationwere correctly
identiﬁed.
The standard VITEK method correctly identi-
ﬁed 163 of 169 (96%) isolates. One E. coli isolate
was misidentiﬁed as S. arizonae, and one isolate of
Salmonella sp. (serovar Schwarzengrund) was mis-
identiﬁed as S. arizonae. Three E. coli isolates were
reported with probability numbers <90% as S.
arizonae (86%), Citrobacter farmeri (73%) and E. coli
(76%), respectively. Finally, one S. paratyphi B
isolate was identiﬁed as a Citrobacter freundii/
youngae with a probability number of 61%.
Table 2 Results of five biochemical tests using the direct VITEK method for 15 misidentified isolates and six isolates with
low probability number (< 90%)
Strain
number
Conventional
identification
VITEK
identificationa
VITEK results
Urease H2S Citrate Malonate Lysine
41 Escherichia coli Kluyvera sp.b – – þ þ þ
50 Escherichia coli Citrobacter amalonaticus – – – – –
52 Escherichia coli Citrobacter farmeri – – – – –
69 Escherichia coli Salmonella sp. – – þ þ þ
116 Escherichia coli Salmonella arizonae – þ þ – þ
121 Escherichia coli Enterobacter amnigenusc – – þ þ –
130 Salmonella sp. Citrobacter freundiid – þ þ – –
131 Escherichia coli Enterobacter cloacae þ – þ þ –
133 Escherichia coli S. arizonae – – þ þ –
138 Escherichia coli S. arizonae – – þ þ þ
150 Escherichia coli E. amnigenuse – – þ þ –
157 Escherichia coli S. arizonae – – – þ þ
159 Escherichia coli E. amnigenusf þ – þ þ –
173 Escherichia coli S. arizonaeg – – þ þ –
175 Escherichia coli S. arizonae – – – þ þ
176 Escherichia coli S. arizonae – – – þ þ
184 Escherichia coli S. arizonae – – þ þ þ
199 Escherichia coli S. arizonae þ – þ þ þ
200 Escherichia coli S. arizonae þ – þ þ þ
205 Escherichia coli S. arizonae þ – þ þ þ
206 Escherichia coli S. arizonae – – þ þ þ
aProbability number >90% if otherwise not stated.
b45% Kluyvera species. ‘Good confidence, marginal separation.’
c40% Enterobacter amnigenus biogroup 2. ‘Questionable biopattern.’
d60% Citrobacter freundii/youngae. ‘Good confidence, marginal separation.’
e40% Enterobacter amnigenus biogroup 2. ‘Questionable biopattern.’
f57% Enterobacter amnigenus biogroup 2. ‘Good confidence, marginal separation.’
g72% Salmonella arizonae. ‘Questionable biopattern.’
Table 3 Percentages of strains correctly identified, not identified or misidentified as a function of detection time
Identification
time (h)
Correct
identification (%)
No
identification (%) Misidentification (%)
Total
number
2 100 0 0 14
3 95 0 5 79
4 92 0 8 12
5 83 0 17 6
6 100 0 0 6
7 0 0 100 1
8 29 55 16 51
Total number 169
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Susceptibility testing
Of the 169 isolates, 140 (125 correctly identiﬁed
and 15 misidentiﬁed) were able to be evaluated for
the direct susceptibility testing method. A total of
29 isolates were excluded, of which 28 were due
to probability numbers of <90% or lack of identi-
ﬁcation, and one was a Serratia marcescens, where
the VITEK expert system cautioned about the
combination of species and susceptibility pattern
found. For the standard susceptibility testing
method, 165 (98%) isolates were able to be evalu-
ated, as four isolates with probability numbers
<90% were excluded.
The overall resistance as determined by the
routine method (n¼ 169) was low: ampicillin
51%, cefuroxime 10%, ceftriaxone 3%, ceftazidime
1%, ciproﬂoxacin 1%, gentamicin <1%, and tobra-
mycin <1%.
The 140 isolates were able to be evaluated for
direct susceptibility testing were assessed for
seven antimicrobial agents, resulting in a total of
980 isolate–antimicrobial combinations. VITEK
gave correct results for 969 (99%) of these combi-
nations. The 11 discrepancies were as follows: one
major error for ciproﬂoxacin with one E. coli iso-
late; one major error with another E. coli isolate for
ceftazidime, cefuroxime and gentamicin (contam-
ination was ruled out by retesting from the control
well of the GNS-GA card); major errors for ampi-
cillin with three misidentiﬁed isolates (E. coli); and
ﬁnally, minor errors with four isolates (one Kleb-
siella pneumoniae and one E. coli for cefuroxime and
two Pseudomonas aeruginosa for ceftriaxone and
ceftazidime, respectively). No difference in accu-
racy was found between correctly identiﬁed iso-
lates (99%, 867/875) and misidentiﬁed isolates
(97%, 102/105). Direct susceptibility testing took
from 3 to 14 h. In fact, 85% were completed within
6 h, and of these, 99% were correct.
For the 165 isolates able to be evaluated for the
standard susceptibility testing method a correct
result was obtained for 1146 (99%) of the 1155
isolate–antimicrobial combinations. Discrepancies
were found in nine combinations, ﬁve of which
involved cefuroxime.
Isolates with both identification and
susceptibility data
After 6 and 8h, direct testing resulted in identiﬁ-
cations and susceptibility patterns for 106 and 109
of the 169 isolates, respectively. After both 6 and
8 h, ﬁve isolates were misidentiﬁed and three iso-
lates yielded false susceptibility testing results,
one very major, one major, and one minor error.
DISCUSSION
In Denmark, we have few problems initiating
antibiotic treatment based on microscopy of blood
cultures with Gram-positive bacteria due to the
low incidences of methicillin-resistant Staphylococ-
cus aureus (<1%) and Streptococcus pneumoniaewith
reduced susceptibility to penicillin (<4%) [15].
This is in contrast to bacteremia caused by
Gram-negative enteric bacilli, where susceptibility
to antimicrobial agents varies to a greater extent.
Consequently, we assessed the accuracy and
speed of identiﬁcation and susceptibility testing
using a direct inoculation method, the GNIþ/
GNS-GA cards, as a prelude to exploring the
possibility of same-day reporting of identiﬁcation
and antibiotic susceptibility testing of blood cul-
tures positive with Gram-negative bacilli.
In thepresent studyusing thedirectmethod, 75%
of isolates were correctly identiﬁed, which is con-
siderably lower thanwhen testing the same isolates
using the standard method, where 96% were cor-
rectly identiﬁed. It is also lower than the ﬁndings of
other studies of direct inoculation of positive blood
cultures, inwhich 92–96%were correctly identiﬁed
[4–6], althoughWaites et al. only found 72% for the
rapid MicroScan panel [7]. Comparison with the
results of the present study is, however, difﬁcult as
different blood culturing systems or identiﬁcation
systems or both were used.
E. coli caused the largest problem of identiﬁca-
tion in the present study; most of the aberrant
identiﬁcations were S. arizonae. Two factors gave
suspicion of misidentiﬁcation. First, S. arizonae is
seldom a cause of bacteremia and has not hitherto
been seen in Denmark; and secondly, 11 of 12
strains misidentiﬁed or identiﬁed with a low prob-
ability number as S. arizonae had negative H2S
reaction and this reaction is 99% positive for S.
arizonae tested conventionally [13], and was also
positive in all six S. arizonae/diarizonae strains
tested from simulated blood cultures. Manually
changing positive reactions in the citrate and/or
malonate tests resulted in correct identiﬁcation for
a majority of E. coli isolates.
By the standard VITEK method, the two mis-
identiﬁcations and two of the four non-identiﬁca-
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tions due to low probability numbers were also
caused by positive malonate tests, pointing at an
inherent tendency of the GNIþ card in this regard.
The GNIþ card is an enhanced version of the GNI
card with faster reporting, improved identiﬁcation
accuracy, and a larger corresponding database
[10]. These improvements, however, might have
made the GNIþ card more prone to false-positive
results. One Danish clinical microbiology labora-
tory has stopped using the GNIþ card and is using
the GNI card instead because of problems with E.
coli identiﬁcation (Jens KMøller, A˚rhus University
Hospital, personal communication). We ﬁnd that
these results justify a request to the manufacturer
to investigate and possibly modify the identiﬁca-
tion algorithm of the VITEK software.
Two other factors might be the cause of the low
percentage of correct identiﬁcations. A washing
stepwas not included in the protocol of the present
study, in contrast to previous studies [5,6]. Thus, it
is possible that traces of blood culture broth or
blood components have interfered with the bio-
chemical reactions.
The results of the antibiotic susceptibility test-
ings were very accurate for both the direct and the
standard method and were as good as those found
by other investigators [6,8,16]. A shortcoming of
these results is that the low level of antibiotic
resistance in Denmark resulted in only a small
number of isolate–antimicrobial combinations that
challenged the system.
The present study was initiated to explore the
possibility of same-day reporting of preliminary
identiﬁcation and susceptibility results to clini-
cians.We chose to accept only identiﬁcationsmade
in 6 h or less, as at this point 95% of the identiﬁca-
tions were correct, and extending the time limit
beyond 6h only increased the percentage of mis-
identiﬁcations. Irrespective of detection time, the
direct inoculation into the VITEK of organisms
incompatible with the GNIþ card (one Bacillus
sp. and 12 anaerobic or fastidious Gram-negative
bacilli) did not result in misidentiﬁcations, as all
were reported as unidentiﬁed or nonviable organ-
isms. In the case of the four polymicrobial blood
cultures, the VITEK reported one as unidentiﬁed,
while the three cultures with different Enterobac-
teriaceae were reported within 6 h with the thera-
peutically ‘appropriate’ susceptibility pattern, i.e.
the pattern of the most resistant bacterium.
At 6 h the VITEK had reported identiﬁcations
plus susceptibility patterns of 106 isolates,
corresponding to 63% of 169 mono-bacteremic
blood cultures with growth of Gram-negative
bacilli intended for the GNIþ card. The cost of
this was ﬁve misidentiﬁcations without therapeu-
tic consequences, and three susceptibility testing
errors.
A practical advantage of the direct procedure
is the fast oxidase test result, which may have
direct implications for the choice of pre-emptive
antimicrobial chemotherapy, i.e. inclusion of an
anti-pseudomonas antibiotic on suspicion of
P. aeruginosa bacteremia.
The direct inoculation method from positive
blood cultures cannot replace approved methods
of identiﬁcation and susceptibility testing because
of the above-mentioned shortcomings of the accu-
racy of identiﬁcation, and because the VITEK can-
not identify anaerobes, fastidious Gram-negative
bacilli, etc., erroneously inoculated after micro-
scopy. But as we believe that same-day reporting
of preliminary blood culture results for about two-
thirds of our patients with Gram-negative bacter-
emia would ensure better patient management, we
plan to work further with this method in order to
improve the clinical utility of our microbiological
testing.
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